Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study

被引：12
作者：
Elberink, Hanneke N. G. [1 ,2 ,3 ]
Jalving, Mathilde [1 ,2 ,3 ]
Dijkstra, Hilda [1 ,2 ,3 ]
van de Ven, Annick A. J. M. [1 ,2 ,3 ]
机构：
[1] Univ Med Ctr Groningen, Dept Allergol & Internal Med, Internal Address Code AA21,Hanzepl 1, NL-9713 GZ Groningen, Netherlands
[2] Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands
[3] Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands
来源：
CLINICAL AND TRANSLATIONAL ALLERGY | 2020年 / 10卷 / 01期
关键词：
Carboplatin; Desensitisation; Drug hypersensitivity; Omalizumab; DESENSITIZATION; OXALIPLATIN;
D O I：
10.1186/s13601-020-0309-0
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
Carboplatin administration can usually be safely continued via a so-called desensitisation protocol when hypersensitivity reactions arise. Severe break-through reactions that occur early during desensitisation are likely to be IgE-mediated; in that case, addition of omalizumab premedication should be strongly considered.
引用
收藏
页数：5
相关论文
共 9 条
  • [1] Anaphylaxis after Elosulfase A infusion: Omalizumab as coadjuvant for enzyme replacement therapy desensitization
    Arroabarren, Esozia
    Aznal, Elena
    Anda, Marta
    Sanchez-Valverde, Felix
    [J]. PEDIATRIC ALLERGY AND IMMUNOLOGY, 2019, 30 (04) : 491 - 494
  • [2] Carboplatin-, Oxaliplatin-, and Cisplatin-specific IgE: Cross-reactivity and Value in the Diagnosis of Carboplatin and Oxaliplatin Allergy
    Caiado, Joana
    Venemalm, Lennart
    Pereira-Santos, Maria Conceicao
    Costa, Luis
    Barbosa, Manuel Pereira
    Castells, Mariana
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (05) : 494 - 500
  • [3] Hypersensitivity reactions to chemotherapy: Outcomes and safety of rapid desensitization in 413 cases
    Castells, Mariana C.
    Tennant, Nichole M.
    Sloane, David E.
    Hsu, F. Ida
    Barrett, Nora A.
    Hong, David I.
    Laidlaw, Tanya M.
    Legere, Henry J.
    Nallamshetty, Samridhi N.
    Palis, Ross I.
    Rao, Jayanti J.
    Berlin, Suzanne T.
    Campos, Susana M.
    Matulonis, Ursula A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 122 (03) : 574 - 580
  • [4] Carboplatin-induced severe hypersensitivity reaction: Role of IgE-dependent basophil activation and FcεRI
    Iwamoto, Takuya
    Hirai, Hiroyuki
    Yamaguchi, Nozomi
    Kobayashi, Natsuki
    Sugimoto, Hiroko
    Tabata, Tsutomu
    Okuda, Masahiro
    [J]. CANCER SCIENCE, 2014, 105 (11): : 1472 - 1479
  • [5] Omalizumab can inhibit respiratory reaction during aspirin desensitization
    Lang, David M.
    Aronica, Mark A.
    Maierson, Elizabeth S.
    Wang, Xiao-Feng
    Vasas, Dorothy C.
    Hazen, Stanley L.
    [J]. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2018, 121 (01) : 98 - 104
  • [6] Clinical features of hypersensitivity reactions to carboplatin
    Markman, M
    Kennedy, A
    Webster, K
    Elson, P
    Peterson, G
    Kulp, B
    Belinson, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (04) : 1141 - 1145
  • [7] Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels
    Ojaimi, Samar
    Harnett, Paul R.
    Fulcher, David A.
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2014, 2 (01) : 105 - 106
  • [8] Unexpected Anaphylaxis After Completing a Desensitization Protocol to Oxaliplatin: Successful Adjuvant Use of Omalizumab
    Prieto-Garcia, A.
    Noguerado, B.
    Rojas, P.
    Torrado, I
    Rodriguez-Fernandez, A.
    Tornero, P.
    [J]. JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2019, 29 (01) : 53 - 55
  • [9] Rituximab and Omalizumab in Severe, Refractory Insulin Allergy
    Yong, Patrick F. K.
    Malik, Rifat
    Arif, Sefina
    Peakman, Mark
    Amiel, Stephanie
    Ibrahim, Mohammad A. A.
    Gough, Andrew
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (10) : 1045 - 1047
1